The store will not work correctly when cookies are disabled.
7,8-dibromo-1-((4-methylpiperazine-1-carbonyl)oxy)phenazine 5,10-dioxide
ID: ALA4746007
Chembl Id: CHEMBL4746007
PubChem CID: 135124745
Max Phase: Preclinical
Molecular Formula: C18H16Br2N4O4
Molecular Weight: 512.16
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: CN1CCN(C(=O)Oc2cccc3c2[n+]([O-])c2cc(Br)c(Br)cc2[n+]3[O-])CC1
Standard InChI: InChI=1S/C18H16Br2N4O4/c1-21-5-7-22(8-6-21)18(25)28-16-4-2-3-13-17(16)24(27)15-10-12(20)11(19)9-14(15)23(13)26/h2-4,9-10H,5-8H2,1H3
Standard InChI Key: VORQZSPYGHODKT-UHFFFAOYSA-N
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 512.16 | Molecular Weight (Monoisotopic): 509.9538 | AlogP: 2.53 | #Rotatable Bonds: 1 |
Polar Surface Area: 86.66 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 0 |
#RO5 Violations: 1 | HBA (Lipinski): 8 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: | CX Basic pKa: 6.71 | CX LogP: 2.29 | CX LogD: 2.21 |
Aromatic Rings: 3 | Heavy Atoms: 28 | QED Weighted: 0.28 | Np Likeness Score: -0.50 |
References
1. Viktorsson, Elvar Orn, Aesoy, Reidun, Stoa, Sindre, Lekve, Viola, Doskeland, Stein Ove, Herfindal, Lars, Rongved, Pal. (2021) New prodrugs and analogs of the phenazine 5,10-dioxide natural products iodinin and myxin promote selective cytotoxicity towards human acute myeloid leukemia cells, 12 (5.0): [PMID:34124675] [10.1039/d1md00020a] |